Metformin

Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including th...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Hōputu: Online
Reo:Ingarihi
I whakaputaina: IntechOpen 2023
Ngā marau:
Urunga tuihono:ONIX_20231201_9781839696060_2113
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
_version_ 1869530394271940608
collection Directory of Open Access Books
description Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including the oral agent metformin. This medication is recommended as first-line treatment for T2D, except for those patients with severe kidney or liver problems. This book discusses the molecular mechanism, pharmacokinetics, and uses of metformin, as well as presents information on adverse drug reactions, drug interactions, and the potential use of metformin in tuberculosis.
format Online
id doab-20.500.12854ir-131002
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-1310022024-04-01T14:15:05Z Metformin Akhtar, Juber Ahmad, Usama Irfan Khan, Mohammad diabetes mellitus, cancer, obesity, antioxidant, insulin, glucose thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including the oral agent metformin. This medication is recommended as first-line treatment for T2D, except for those patients with severe kidney or liver problems. This book discusses the molecular mechanism, pharmacokinetics, and uses of metformin, as well as presents information on adverse drug reactions, drug interactions, and the potential use of metformin in tuberculosis. 2023-12-01T18:39:13Z 2023-12-01T18:39:13Z 2021 book ONIX_20231201_9781839696060_2113 9781839696060 9781839696053 9781839696077 https://directory.doabooks.org/handle/20.500.12854/131002 eng image/jpeg n/a https://www.intechopen.com/books/10735 https://mts.intechopen.com/storage/books/10735/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.94707 10.5772/intechopen.94707 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781839696060 9781839696053 9781839696077 IntechOpen 154 open access
spellingShingle diabetes mellitus, cancer, obesity, antioxidant, insulin, glucose
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Metformin
title Metformin
title_full Metformin
title_fullStr Metformin
title_full_unstemmed Metformin
title_short Metformin
title_sort metformin
topic diabetes mellitus, cancer, obesity, antioxidant, insulin, glucose
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
topic_facet diabetes mellitus, cancer, obesity, antioxidant, insulin, glucose
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
url ONIX_20231201_9781839696060_2113